| Application no. and date | 21723277.6 (espacenet) (Federated) (European Patent Register), 20210507 | | Patent/reg. no. and date | DK/EP 4147053, 20260128 | | Publication date | 20230315 | | Priority no. and date | EP 20305454, 20200507 | | EP pub. no. and date |
EP 4147053 20230315 | | Effective date | | | Applicant/owner | Institut Curie, 26, rue d'Ulm
75248 Paris Cedex 05, FR,
Institut National de la Santé et de la
Recherche Médicale (INSERM), 101 rue de Tolbiac
75013 Paris, FR | | Applicant ref. no. | | | Inventor | MECHTA-GRIGORIOU, Fatima,
94100 SAINT MAUR DES FOSSES, FR,
KIEFFER, Yann,
94700 MAISONS-ALFORT, FR,
VINCENT-SALOMON, Anne,
75013 PARIS, FR,
HOCINE, Rachid, Hocine,
MANHATTAN, NEW YORK 10021, US | | Representative | | | Opponent | | | IPC Class | C07K 16/00 (2006.01) , G01N 33/574 (2006.01) | | Title | ANTXR1 AS A BIOMARKER OF IMMUNOSUPPRESSIVE FIBROBLAST POPULATIONS AND ITS USE FOR PREDICTING RESPONSE TO IMMUNOTHERAPY | | Int. application no. | EP2021062090 | | Int. publication no. | WO2021224438 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
